close-up-microphone-news-and-events close-up-microphone-news-and-events

Press Releases

Press Release: Sixth-Annual Patient Choice Awards

By Kelly Mullin

MMIT Announces Sixth-Annual Specialty Pharmacy Patient Choice Awards Finalists

Finalists across four categories represent leading specialty pharmacies with a dedication to top-notch customer satisfaction.

Aug. 3, 2021, Yardley, PA – Managed Markets Insight & Technology (MMIT), the trusted go-to-market partner solely focused on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving drugs—has announced the finalists of the sixth-annual Specialty Pharmacy Patient Choice Awards—based on patient satisfaction survey results from the previous year.

Each year, MMIT recognizes specialty pharmacies that provide best-in-class customer satisfaction and overall patient care within four categories: Payer/PBM, Hospital and Health System, Independent and Retail. The finalists and winners are calculated based on the highest average Net Promoter Score (NPS) from the Zitter Insights Specialty Pharmacy Patient Satisfaction Survey, which provides clients with data they can trust to help them improve patient satisfaction and increase scripts. NPS is a well-established research method that measures customer satisfaction.

“We’re thrilled to once again recognize those who are leading the pack in the specialty pharmacy industry,” said MMIT CEO Mike Gallup. “2020 was a challenging year, but these organizations demonstrated an unwavering commitment to their patients. Congratulations to all of the finalists.”

The finalists include:

Hospital & Health System Specialty Pharmacy:

Independent Specialty Pharmacy:

Payer/PBM Specialty Pharmacy:

Retail Specialty Pharmacy:

The winners will be announced at an awards ceremony hosted by MMIT at the Asembia Specialty Pharmacy Summit, held Oct. 26-29 in Las Vegas.

© 2024 MMIT
Kelly Mullin

Kelly Mullin Digital Marketing Specialist

Related Posts

June 20

With IRA Impacts Looming, Manufacturers Should Focus on Providing Patient Support

Read More
June 20

FDA Moves Bring Total Biosimilar Approvals to 53

Read More
June 20

Report: Led by Anti-Inflammatories, Specialty Drugs Continue Upward Trend

Read More


Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today